| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Medicine, the University of Sydney, NSW 2006 [A. C., S. H. M., Q. D.]; Departments of Anatomical Pathology [P. R.] and Urology [J. R.] and Kanematsu Laboratories [D. S. M., S. J. C.], Royal Prince Alfred Hospital, NSW 2050; and ANZAC Research Institute and Departments of Andrology [D. J. H.] and Anatomical Pathology [S. M.], Concord Repatriation General Hospital, NSW 2139, Australia
Annexin II mRNA coding for a calcium binding protein was found to be absent in prostate cancer by subtractive hybridization and Northern analysis. In contrast to high expression in normal and benign hyperplastic glandular and basal epithelium, Annexin II heavy (p36) and light (p11) chains in 31/31 prostate cancer specimens were lost immunohistochemically. In glands involved by prostate intraepithelial neoplasia, 65% lost both chains in glandular epithelial cells, whereas basal cells were all positively stained. Southern analysis of cancer DNA showed no noticeable deletion in p36 gene. LNCaP cells treated with 5-azacytidine re-expressed p36, suggesting methylation could be responsible for the silencing.
This article has been cited by other articles:
![]() |
M. E. Padula, M. L. Sydnor, and D. W. Wilson Isolation and Preliminary Characterization of Herpes Simplex Virus 1 Primary Enveloped Virions from the Perinuclear Space J. Virol., May 15, 2009; 83(10): 4757 - 4765. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Assinder, Q. Dong, H. Mangs, and D. R. Richardson Pharmacological Targeting of the Integrated Protein Kinase B, Phosphatase and Tensin Homolog Deleted on Chromosome 10, and Transforming Growth Factor-{beta} Pathways in Prostate Cancer Mol. Pharmacol., March 1, 2009; 75(3): 429 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Patel, J. Singh, M. Niknami, C. Kurek, M. Yao, S. Lu, F. Maclean, N. J.C. King, M. H. Gelb, K. F. Scott, et al. Cytosolic Phospholipase A2-{alpha}: A Potential Therapeutic Target for Prostate Cancer Clin. Cancer Res., December 15, 2008; 14(24): 8070 - 8079. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hastie, J. R. Masters, S. E. Moss, and S. Naaby-Hansen Interferon-{gamma} Reduces Cell Surface Expression of Annexin 2 and Suppresses the Invasive Capacity of Prostate Cancer Cells J. Biol. Chem., May 2, 2008; 283(18): 12595 - 12603. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, I.-m. Shih, R. Salani, D. W. Chan, and Z. Zhang Annexin XI Is Associated with Cisplatin Resistance and Related to Tumor Recurrence in Ovarian Cancer Patients Clin. Cancer Res., November 15, 2007; 13(22): 6842 - 6849. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stewart, N. Fleshner, H. Cole, and J. Sweet Comparison of annexin II, p63 and {alpha}-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study J. Clin. Pathol., July 1, 2007; 60(7): 773 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Wang, T.-T. Wu, E. Resetkova, H. Wang, A. M. Correa, W. L. Hofstetter, S. G. Swisher, J. A. Ajani, A. Rashid, S. R. Hamilton, et al. Expression of Annexin A1 in Esophageal and Esophagogastric Junction Adenocarcinomas: Association with Poor Outcome Clin. Cancer Res., August 1, 2006; 12(15): 4598 - 4604. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. P. Yu, S. Paranjpe, J. Nelson, S. Finkelstein, B. Ren, D. Kokkinakis, G. Michalopoulos, and J.-H. Luo High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array Carcinogenesis, February 1, 2005; 26(2): 471 - 479. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sved, K. F. Scott, D. McLeod, N. J. C. King, J. Singh, T. Tsatralis, B. Nikolov, J. Boulas, L. Nallan, M. H. Gelb, et al. Oncogenic Action of Secreted Phospholipase A2 in Prostate Cancer Cancer Res., October 1, 2004; 64(19): 6934 - 6940. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fernandez-Madrid, N. Tang, H. Alansari, J. L. Granda, L. Tait, K. C. Amirikia, M. Moroianu, X. Wang, and R. L. Karvonen Autoantibodies to Annexin XI-A and Other Autoantigens in the Diagnosis of Breast Cancer Cancer Res., August 1, 2004; 64(15): 5089 - 5096. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Sun, M. Gulyas, and A. Hjerpe Mesothelial Differentiation as Reflected by Differential Gene Expression Am. J. Respir. Cell Mol. Biol., April 1, 2004; 30(4): 510 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Filipenko, T. J. MacLeod, C.-S. Yoon, and D. M. Waisman Annexin A2 Is a Novel RNA-binding Protein J. Biol. Chem., March 5, 2004; 279(10): 8723 - 8731. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Garcia Pedrero, M. P. Fernandez, R. O. Morgan, A. Herrero Zapatero, M. V. Gonzalez, C. Suarez Nieto, and J. P. Rodrigo Annexin A1 Down-Regulation in Head and Neck Cancer Is Associated with Epithelial Differentiation Status Am. J. Pathol., January 1, 2004; 164(1): 73 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kirshner, D. Schumann, and J. E. Shively CEACAM1, a Cell-Cell Adhesion Molecule, Directly Associates with Annexin II in a Three-dimensional Model of Mammary Morphogenesis J. Biol. Chem., December 12, 2003; 278(50): 50338 - 50345. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. She, S. Narindrasorasak, S. Yang, N. Spitale, E. A. Roberts, and B. Sarkar Identification of Metal-binding Proteins in Human Hepatoma Lines by Immobilized Metal Affinity Chromatography and Mass Spectrometry Mol. Cell. Proteomics, December 1, 2003; 2(12): 1306 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Seth, M. A. Leo, P. H. McGuinness, C. S. Lieber, Y. Brennan, R. Williams, X. M. Wang, G. W. McCaughan, M. D. Gorrell, and P. S. Haber Gene Expression Profiling of Alcoholic Liver Disease in the Baboon (Papio hamadryas) and Human Liver Am. J. Pathol., December 1, 2003; 163(6): 2303 - 2317. [Abstract] [Full Text] |
||||
![]() |
T. J. MacLeod, M. Kwon, N. R. Filipenko, and D. M. Waisman Phospholipid-associated Annexin A2-S100A10 Heterotetramer and Its Subunits: CHARACTERIZATION OF THE INTERACTION WITH TISSUE PLASMINOGEN ACTIVATOR, PLASMINOGEN, AND PLASMIN J. Biol. Chem., July 3, 2003; 278(28): 25577 - 25584. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Calvo, N. Xiao, J. Kang, C. J. M. Best, I. Leiva, M. R. Emmert-Buck, C. Jorcyk, and J. E. Green Alterations in Gene Expression Profiles during Prostate Cancer Progression: Functional Correlations to Tumorigenicity and Down-Regulation of Selenoprotein-P in Mouse and Human Tumors Cancer Res., September 15, 2002; 62(18): 5325 - 5335. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gerke and S. E. Moss Annexins: From Structure to Function Physiol Rev, April 1, 2002; 82(2): 331 - 371. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |